BioCentury
ARTICLE | Clinical News

Aironite: Phase IIa amended

March 2, 2015 8:00 AM UTC

Mast said the University of Pittsburgh amended an open-label, U.S. Phase IIa trial of 45 and 90 mg inhaled AIR001 to include 20 patients with WHO group II pulmonary hypertension (PH) and PH associate...